![Debora Barton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Debora Barton
Directeur/Bestuurslid bij
American Cancer Society, Inc.
Vermogen: 54 889 $ op 31-08-2026
Profiel
Debora Barton is currently the Director at American Cancer Society, Inc. since 2018.
Formerly, Dr. Barton was an Independent Non-Executive Director at Arovella Therapeutics Ltd. from 2021 to 2026, Senior VP, Head-Clinical & Safety at Iovance Biotherapeutics, Inc. from 2018 to 2019, Chief Medical Officer at CTx Operations, Inc. from 2019 to 2022, Chief Medical Officer at Carisma Therapeutics, Inc. from 2019 to 2022, and Chief Medical Officer at TScan Therapeutics, Inc. from 2022 to 2024.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-05-2026 | 1.276.490 ( 0,11% ) | 54 889 $ | 31-08-2026 |
Actieve functies van Debora Barton
| Bedrijven | Functie | Begin |
|---|---|---|
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates voluntary health organization for cancer research | Directeur/Bestuurslid | 01-05-2018 |
Eerdere bekende functies van Debora Barton
| Bedrijven | Functie | Einde |
|---|---|---|
| AROVELLA THERAPEUTICS LIMITED | Directeur/Bestuurslid | 04-05-2026 |
| TSCAN THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 08-04-2024 |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology Develops macrophage-based immunotherapeutic for treatment of cancer | Hoofd Techniek/Wetenschap/O&O | 01-06-2022 |
| CARISMA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-06-2022 |
| IOVANCE BIOTHERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-11-2019 |
Opleiding van Debora Barton
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
63
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Arovella Therapeutics Ltd.
 Arovella Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and distributes medical devices and consumables | Health Technology |
American Cancer Society, Inc.
American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates voluntary health organization for cancer research | Commercial Services |
Pontifícia Universidade Católica de São Paulo
 Pontifícia Universidade Católica de São Paulo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology Develops macrophage-based immunotherapeutic for treatment of cancer | Health Technology |
TScan Therapeutics, Inc.
 TScan Therapeutics, Inc. BiotechnologyHealth Technology Develops T-cell therapies for cancer patients | Health Technology |
Carisma Therapeutics, Inc.
 Carisma Therapeutics, Inc. BiotechnologyHealth Technology Develops novel chimeric antigen receptor macrophage and CAR-monocyte technology treatment of non-muscle invasive bladder cancer | Health Technology |
